tradingkey.logo
tradingkey.logo
Search

Ardent Health Partners Inc

ARDT
Add to Watchlist
8.910USD
-0.160-1.76%
Close 06/18, 16:00ETQuotes delayed by 15 min
1.28BMarket Cap
9.36P/E TTM

Earnings Forecast

Currency: USD Updated: 2026-06-18
Previous score
7.50
Change
0
The current earnings forecast score of Ardent Health Partners Inc is 7.50, ranking 41 out of 76 in the Healthcare Providers & Services industry. The average price target is 14.75, with a high of 20.00 and a low of 10.00.

Analyst Rating

Based on 12 analysts
Buy
Current Rating
12.550
Target Price
+40.85%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

68
Total
8
Median
9
Average
Company name
Ratings
Analysts
Ardent Health Partners Inc
ARDT
12
CVS Health Corp
CVS
29
Teladoc Health Inc
TDOC
27
HCA Healthcare Inc
HCA
26
Tenet Healthcare Corp
THC
23
Natera Inc
NTRA
23
1
2
3
...
14

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

FAQs

What is Ardent Health Partners Inc's expected revenue for the next quarter?

Ardent Health Partners Inc's expected revenue is 1.64B.

What is Ardent Health Partners Inc's price target?

Analysts forecast that Ardent Health Partners Inc's price target is USD 14.75, with the highest forecast at USD 20.00 and the lowest forecast at USD 10.00.

How have Ardent Health Partners IncARDT's recent earnings per share performed?

The market expectation was USD 0.28, while Ardent Health Partners IncARDT's earnings per share (EPS) for the previous quarter was USD 0.32. EPS for the next quarter is expected at USD 0.25.

What is the analyst rating for Ardent Health Partners Inc?

Based on the ratings of Ardent Health Partners Inc's stock from 12 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
KeyAI